Hormone replacement therapy and risk of breast cancer: Results from epidemiologic studies

Treth, 1990, The effect of premorbid height and weight on the survival of breast cancer patients, Br J Cancer, 62, 299, 10.1038/bjc.1990.282

Key, 1988, The role of oestrogens and progestogens in the epidemiology and prevention of breast cancer, Eur J Cancer Clin Oncol, 24, 29, 10.1016/0277-5379(88)90173-3

Colditz, 1992, Postmenopausal hormone use and risk of breast cancer, twelve year follow-up of the Nurses' Health Study, 63

Mills, 1989, Prospective study of exogenous hormone use and breast cancer in Seventh-Day Adventists, Cancer, 64, 591, 10.1002/1097-0142(19890801)64:3<591::AID-CNCR2820640305>3.0.CO;2-U

Armstrong, 1988, Estrogen therapy after the menopause—boon or bane?, Med J Aust, 148, 213, 10.5694/j.1326-5377.1988.tb99424.x

Steinberg, 1991, A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer, JAMA, 265, 1985, 10.1001/jama.1991.03460150089030

Dupont, 1991, Menopausal estrogen replacement therapy and breast cancer, Arch Intern Med, 151, 67, 10.1001/archinte.1991.00400010089011

Sillero-Arenas, 1992, Menopausal hormone replacement therapy and breast cancer: a meta-analysis, Obstet Gynecol, 79, 286

DerSimonian, 1986, Meta-analysis in clinical trials, Controlled Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2

Greenland, 1988, Quantitative methods in the review of epidemiologic literature, Epidemiol Rev, 9, 1, 10.1093/oxfordjournals.epirev.a036298

Bland, 1980, The effects of exogenous estrogen replacement therapy of the breast. Breast cancer risk and mammographic parenchymal patterns, Cancer, 45, 3027, 10.1002/1097-0142(19800615)45:12<3027::AID-CNCR2820451225>3.0.CO;2-2

Lauritzen, 1984, Risks of endometrial and mammary cancer morbidity and mortality in long-term estrogen treatment

Craig, 1983, Epidemiologic comparison of breast cancer patients with early and late onset of malignancy and general population controls, J Natl Cancer Inst, 53, 1577

Hammond, 1979, Effects of long-term estrogen replacement therapy. II. Neoplasia, Am J Obstet Gynecol, 133, 537, 10.1016/0002-9378(79)90289-8

Gambrell, 1984, Hormones in the etiology and prevention of breast and endometrial cancer, South Med J, 77, 1509, 10.1097/00007611-198412000-00009

Wynder, 1978, The epidemiology of breast cancer in 785 United States Caucasian women, Cancer, 41, 2341, 10.1002/1097-0142(197806)41:6<2341::AID-CNCR2820410637>3.0.CO;2-N

McDonald, 1986, Menopausal estrogen use and risk of breast cancer, Breast Cancer Res Treat, 7, 193, 10.1007/BF01806250

Hiatt, 1984, Exogenous estrogen and breast cancer after bilateral oophorectomy, Cancer, 54, 139, 10.1002/1097-0142(19840701)54:1<139::AID-CNCR2820540128>3.0.CO;2-X

Ross, 1980, A case-control study of menopausal estrogen therapy and breast cancer, JAMA, 243, 1635, 10.1001/jama.1980.03300420019018

Jick, 1980, Replacement estrogens and breast cancer, Am J Epidemiol, 112, 586, 10.1093/oxfordjournals.aje.a113031

Raynihar, 1979, An epidemiologic study of breast cancer and benign breast neoplasias in relation to oral contraceptive and estrogen use, Eur J Cancer, 15, 395, 10.1016/0014-2964(79)90074-4

Adami, 1989, Risk of cancer in women receiving hormone replacement therapy, Int J Cancer, 44, 833, 10.1002/ijc.2910440515

Adami, 1992, 93

Hunt, 1990, Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis, Br J Obstet Gynaecol, 97, 1080, 10.1111/j.1471-0528.1990.tb02494.x